Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Cancer Molecular Imaging"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (30 April 2020) | Viewed by 40234
Special Issue Editors
Interests: discovery and development of new methods for experimental; clinical cancer molecular imaging
Interests: PET radiochemistry; drug and radiopharmaceutical discovery; clinical translation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Molecular imaging in oncology forms the keystone of personalised medicine and allows the interrogation of cancer pharmacology from a minimally invasive scan. The development of new functional imaging radiopharmaceuticals and their rapid implementation in phase I clinical trials is a facet of molecular imaging that has resulted in many promising radiopharmaceuticals that are likely to bring tremendous benefits to patients.
This Special Issue aims to consolidate the bench-to-bedside journey for developing radiopharmaceuticals. We welcome submissions that contribute to the field of Cancer Molecular Imaging, with focus towards selecting lead candidates from compound libraries, implementing radiochemistry, GMP manufacture and clinical translation. The field of molecular imaging is diverse, spanning from small molecule compounds to large biomolecule targeting vectors and from receptor-based radioligands to metabolism tracers; therefore, we hope to reflect the diversity of our field in this Special Issue.
Prof. Dr. Eric O. Aboagye
Dr. Louis Allott
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Radiopharmaceutical development
- Radioligand screening
- Radiolabeled biomolecules
- Cancer pharmacology
- Imaging metabolism
- Receptor imaging
- PET radiochemistry
- GMP manufacture
- Clinical translation